… in patients with acute coronary syndrome (ACS) and percutaneous coronary intervention to
… strategies addressed in this article include the following—(1) use of more potent antiplatelet …

… scheduled for coronary stenting at 38 centers to a strategy of … to antiplatelet therapy, or to
a conventional strategy without … of death, myocardial infarction, stent thrombosis, stroke, or …

… intervention using new-generation drug-eluting stents without compromising the … strategy
relative to the dual antiplatelet therapy strategy in patients undergoing percutaneous coronary …

Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention (PCI)…

… Dual antiplatelet therapy (DAPT), the combination of aspirin (ASA), and a P2Y 12 … stent
thrombosis and new atherothrombotic events after a stent implantation or an acute coronary …

… In a study of 190 patients undergoing coronary stenting, increasing the loading dose from …
patients with stable coronary artery disease undergoing percutaneous coronary intervention (…

… of adequately tailoring the choice of therapeutic strategy to the individual patient, both with
respect to the choice of stent and combination of anticoagulant and/or antiplatelet therapy. …

… We conclude that there is insufficient evidence to guide perioperative APT management in
patients with coronary stents undergoing NCS. For now, the decision must be tailored to the …

… antiplatelet drugs to provide clinicians with a guide to appropriate antiplatelet strategies. …
Several trials in patients undergoing elective coronary stenting for stable coronary artery …

… In the present study, we roughly checked the cost outcomes of LTA screening based optimizing
antiplatelet strategy. The results showed that, even with six months cilostazol treatment, …